Groningen, The Netherlands, 07 January 2020 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced today that it has obtained CE marking for LIQOSEAL®, its easy-to-use and innovative dural sealant patch, and will launch the device in Europe with immediate effect. Approval of the CE mark is based on outstanding […]
Groningen, The Netherlands, 17 September 2019 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, has today announced positive data from its ENCASE I* clinical trial. The ENCASE I trial is focused on the evaluation of the safety and performance of LIQOSEAL® in reducing cerebrospinal fluid (CSF) leakage following elective cranial […]
Groningen, The Netherlands, 10 April 2019 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, is expanding its capacity with a new facility at the Zernike Campus, Groningen, to enter a new phase of commercial and R&D growth. Polyganics has been awarded a subsidy of €3.8 million by the Regional Investment […]
13th congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) June, 2- June 5, 2019 Amsterdam, The Netherlands
American Association of Neurological Surgeons (AANS) – 2019 Annual Scientific Meeting April 13- April 17, 2019 San Diego, California, USA
Cognitive Neuroscience Society (CNS) – 2019 Annual Meeting March 23- March 26, 2019 San Fransisco, California, USA
American Association of Orthopedics (AAOS) – 2019 Annual Meeting (Synovis) 12 March- 16 March, 2019 Las Vegas, Nevada, USA
American Society for Surgery of the Hand (ASSH) – 74th Annual Meeting September 5- September 7, 2019 Las Vegas, Nevada, USA
